These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36478376)

  • 1. Examination of the pharmacokinetics and differential inhibition of cyclooxygenase isoenzymes in New Zealand white rabbits (Oryctolagus cuniculus) by the Non-Steroidal anti-inflammatory Robenacoxib.
    Jeffrey A; Gardhouse S; Kleinhenz M; Hocker SE; Weeder M; Montgomery SR; Zhang Y; Porting A; Rooney T
    J Vet Pharmacol Ther; 2023 Mar; 46(2):103-111. PubMed ID: 36478376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2.
    King JN; Dawson J; Esser RE; Fujimoto R; Kimble EF; Maniara W; Marshall PJ; O'Byrne L; Quadros E; Toutain PL; Lees P
    J Vet Pharmacol Ther; 2009 Feb; 32(1):1-17. PubMed ID: 19161451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology, safety, efficacy and clinical uses of the COX-2 inhibitor robenacoxib.
    Lees P; Toutain PL; Elliott J; Giraudel JM; Pelligand L; King JN
    J Vet Pharmacol Ther; 2022 Jul; 45(4):325-351. PubMed ID: 35460083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of cyclooxygenase isoenzymes in the cat by the NSAID robenacoxib.
    Giraudel JM; Toutain PL; King JN; Lees P
    J Vet Pharmacol Ther; 2009 Feb; 32(1):31-40. PubMed ID: 19161453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and ex vivo inhibition of COX isoforms by robenacoxib in the cat: a comparative study.
    Schmid VB; Seewald W; Lees P; King JN
    J Vet Pharmacol Ther; 2010 Oct; 33(5):444-52. PubMed ID: 20840388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of Cyclooxygenase Products in Plasma as Markers for Inhibition of Cyclooxygenase Isoforms by Oral Meloxicam in New Zealand White Rabbits (
    Sarvi JY; Gardhouse SM; Kleinhenz MD; Hocker SE; Weeder MM; Montgomery SR; Rooney TA
    J Am Assoc Lab Anim Sci; 2023 May; 62(3):254-259. PubMed ID: 37045554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation.
    Pelligand L; King JN; Toutain PL; Elliott J; Lees P
    J Vet Pharmacol Ther; 2012 Feb; 35(1):19-32. PubMed ID: 21767277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential pharmacokinetics and pharmacokinetic/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammation.
    Pelligand L; King JN; Hormazabal V; Toutain PL; Elliott J; Lees P
    J Vet Pharmacol Ther; 2014 Aug; 37(4):354-66. PubMed ID: 24628410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study.
    King JN; Rudaz C; Borer L; Jung M; Seewald W; Lees P
    Res Vet Sci; 2010 Jun; 88(3):497-506. PubMed ID: 20004922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of oral robenacoxib in the cat.
    King JN; Hotz R; Reagan EL; Roth DR; Seewald W; Lees P
    J Vet Pharmacol Ther; 2012 Jun; 35(3):290-300. PubMed ID: 21736587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the dose-response relationship of oral robenacoxib in urate crystal-induced acute stifle synovitis in dogs.
    Borer LR; Seewald W; Peel JE; King JN
    J Vet Pharmacol Ther; 2017 Apr; 40(2):148-157. PubMed ID: 27493016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robenacoxib in the dog: target species safety in relation to extent and duration of inhibition of COX-1 and COX-2.
    King JN; Arnaud JP; Goldenthal EI; Gruet P; Jung M; Seewald W; Lees P
    J Vet Pharmacol Ther; 2011 Jun; 34(3):298-311. PubMed ID: 21492194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Cyclooxygenase(COX)-1 and COX-2 inhibition on furosemide-induced renal responses and isoform immunolocalization in the healthy cat kidney.
    Pelligand L; Suemanotham N; King JN; Seewald W; Syme H; Smith K; Lees P; Elliott J
    BMC Vet Res; 2015 Dec; 11():296. PubMed ID: 26634699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog.
    Schmid VB; Spreng DE; Seewald W; Jung M; Lees P; King JN
    J Vet Pharmacol Ther; 2010 Apr; 33(2):118-31. PubMed ID: 20444036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and ex vivo pharmacodynamics of oral firocoxib administration in New Zealand White rabbits (Oryctolagus cuniculus).
    Gardhouse S; Kleinhenz M; Hocker SE; Weeder M; Montgomery SR; Zhang Y; Porting A; Rooney T
    Am J Vet Res; 2022 May; 83(7):. PubMed ID: 35930777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of route of administration and feeding schedule on pharmacokinetics of robenacoxib in cats.
    King JN; Jung M; Maurer MP; Schmid VB; Seewald W; Lees P
    Am J Vet Res; 2013 Mar; 74(3):465-72. PubMed ID: 23438125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of oral robenacoxib (tablet) for the treatment of pain associated with soft tissue surgery in client-owned dogs.
    Friton G; Thompson CM; Karadzovska D; King S; King JN
    BMC Vet Res; 2017 Jun; 13(1):197. PubMed ID: 28651573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robenacoxib versus meloxicam for the management of pain and inflammation associated with soft tissue surgery in dogs: a randomized, non-inferiority clinical trial.
    Gruet P; Seewald W; King JN
    BMC Vet Res; 2013 May; 9():92. PubMed ID: 23638669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety evaluation of the interchangeable use of robenacoxib (Onsior™) tablets and solution for injection in dogs.
    Toutain CE; Heit MC; King SB; Helbig R
    BMC Vet Res; 2017 Nov; 13(1):359. PubMed ID: 29179750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.